Theravance Biopharma (TBPH) Financials

$17.03

$0.02 (0.12%)

As on 14-Sep-2026 16:00EDT

Market cap

$883 Mln

Revenue (TTM)

$104 Mln

P/E Ratio

16.4

P/B Ratio

3.1

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	238.54	-11.54	-27.00	-186.99	-207.86
Cash Flow from Investing Activities	--	-105.28	12.28	-32.70	1,154.01	124.49
Cash from Financing Activities	--	-3.25	-2.50	-198.93	-758.81	91.86
Net Cash Inflow / Outflow	--	--	--	--	208.21	8.50

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	1.01	2.00	-1.14	-1.12	12.94	-2.70
Cash EPS ($)	1.04	2.05	-1.07	-1.02	13.04	-2.57
Adjusted Book Value ($)	5.58	5.59	3.56	4.31	6.56	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	4.50	-0.23	-0.55	-2.77	-2.81
Free Cash Flow per Share ($)	--	4.50	-0.24	-0.60	-2.78	-2.86

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	35.44	-23.14	-14.60	211.45	-56.70
ROE (%)	18.35	44.85	-29.04	-16.86	1,689.74	62.10
ROA (%)	10.97	25.22	-15.33	-11.16	177.58	-47.26
EBIT Margin (%)	61.61	122.56	-65.34	-93.43	-154.09	-429.65
Net Margin (%)	51.58	98.54	-87.63	-96.11	1,533.90	-124.32
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	35.11	0.67	0.12	0.12	-0.07	-0.23
EBIT Growth (%)	50.13	413.08	21.59	32.19	66.71	19.39
Net Profit Growth (%)	312.92	287.70	-2.22	-106.33	537.32	28.27
EPS Growth (%)	331.49	2.74	-0.02	-1.09	5.80	0.38
Book Value Growth (%)	26.50	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	16.36	9.37	-8.22	-10.06	0.87	-4.10
Price / Book Value	3.05	3.35	2.64	2.61	1.71	-2.41
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	8.59	5.49	-11.06	-9.72	-6.32	-5.64
Close Price ($)	17.00	18.71	9.41	11.24	11.22	11.05
High Price ($)	21.03	20.33	11.71	12.03	13.17	22.74
Low Price ($)	10.82	7.90	7.44	8.25	7.53	6.10
Market Cap ($ Cr)	883.14	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.25	0.28	0.23	0.12	-1.98
Short term debt to equity ratio	0.04	0.04	0.06	0.02	0.02	-0.05
Current Ratio	13.54	10.93	5.02	5.39	12.31	4.26
Quick Ratio	13.54	--	7.16	5.39	12.26	4.09
Interest Coverage	51.97	53.52	-16.52	-22.83	-12.42	-27.80

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.54	88.90	106.30	30.43	32.69	104.14
Asset Turnover	0.21	0.26	0.17	0.12	0.10	0.13
Receivable days	--	278.67	243.71	108.95	264.57	420.20
Inventory Days	--	-4,537.51	-332.39	6.80	33.87	28.87
Payable days	--	159.28	18.27	13.84	13.40	9.31
Cash Conversion Cycle	--	-4,418.12	-106.96	101.92	285.04	439.77

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.